PTEN(10 号染色体上缺失的磷酸酶和张力蛋白同源物)是一种磷酸肌醇 3-磷酸酶,是胰岛素依赖性信号的重要调节剂。PTEN 的缺失或受损会产生抗糖尿病影响,因此有人认为 PTEN 可能是治疗 II 型糖尿病药物的重要靶点。PTEN 具有更宽的活性位点裂隙,使其能够结合 PtdIns(3,4,5)P3 底物。一种高效且特异性的 PTEN 抑制剂,可在纳摩尔浓度下增加细胞 PtdIns(3,4,5)P3 水平、Akt 磷酸化和脂肪细胞中的葡萄糖摄取。
PTEN (Phosphatase and tensin homologue deleted on chromosome 10), a phosphoinositide 3-phosphatase, is an important regulator of insulin-dependent signaling. The loss or impairment of PTEN results in an antidiabetic impact, which led to the suggestion that PTEN could be an important target for drugs against type II diabetes. PTEN has a much wider active site cleft enabling it to bind the PtdIns(3,4,5)P3 substrate. a highly potent and specific inhibitor of PTEN that increases cellular PtdIns(3,4,5)P3 levels, phosphorylation of Akt, and glucose uptake in adipocytes at nanomolar concentrations.
EGFR-IN-192 是一种抗癌剂,可抑制 EGFR (IC50: 0.12 μM),下调 HIF-VEGF 和 PI3K/AKT/mTOR 通路,上调抑癌基因 PTEN,诱导肿瘤细胞周期阻滞与凋亡 (apoptosis),具有抗肿瘤活性,可用于肿瘤的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号